Clinical Spectrum,Risk Factors and Outcome of Immune Reconstitution Inflammatory Syndrome in Patients with Tuberculosis–HIV Coinfection

Corbett E.L. , Watt C.J. , Walker N. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009–1021.

Manosuthi W. , Chottanapand S. , Thongyen S. , Chaovavanich A. , Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 43: 42–46.

Blanc F.X. , Sok T. , Laureillard D. Significant enhancement in survival with early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis. XVIII International AIDS Conference. 18–23 July 2010, Vienna, Austria. Abstract THLBB106.

Seddiki N. , Sasson S.C. , Santner-Nanan B. Proliferation of weakly suppressive regulatory CD4⁺ T cells is associated with over-active CD4⁺ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. Eur J Immunol 2009; 39: 391–403.

Oliver B.G. , Elliott J.H. , Price P. Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. J Infect Dis 2010; 202: 1728–1737.

Kestens L. , Seddiki N. , Bohjanen P.R. Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy. Curr Opin HIV AIDS 2008; 3: 419–424.

Antonelli L.R. , Mahnke Y. , Hodge J.N. Elevated frequencies of highly activated CD4⁺ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood 2010; 116: 3818–3827.

Bourgarit A. , Carcelain G. , Martinez V. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006; 20: F1–F7.

Bourgarit A. , Carcelain G. , Samri A. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells. J Immunol 2009; 183: 3915–3923.

Murdoch D.M. , Venter W.D. , Feldman C. , Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 2008; 22: 601–610.

Michailidis C. , Pozniak A.L. , Mandalia S. , Basnayake S. , Nelson M.R. , Gazzard B.G. Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis. Antivir Ther 2005; 10: 417–422.

Manabe Y.C. , Campbell J.D. , Sydnor E. , Moore R.D. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007; 46: 456–462.

Burman W. , Weis S. , Vernon A. Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis 2007; 11: 1282–1289.

Karmakar S. , Sharma S.K. , Vashishtha R. Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART. Clin Dev Immunol 2011; 2011: 239021.

Shelburne S.A. , Visnegarwala F. , Darcourt J. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005; 19: 399–406.

Leone S. , Nicastri E. , Giglio S. , Narciso P. , Ippolito G. , Acone N. Immune reconstitution inflammatory syndrome associated with Mycobacterium tuberculosis infection: a systematic review. Int J Infect Dis 2010; 14: e283–e291.

Meintjes G. , Lawn S.D. , Scano F. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008; 8: 516–523.

Worodria W. , Massinga-Loembe M. , Mazakpwe D. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr 2011; 58: 32–37.

World Health Organization. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings. (Accessed 21 August 2011.) Available from http://whqlibdoc.who.int/hq/2007/WHO_HTM_TB_2007.379_eng.pdf.

Republic of Uganda Ministry of Health. National antiretroviral treatment and care guidelines for adults, adolescents, and children. (Updated July 2008. Accessed 31 August 2011.) Available from http://www.who.int/hiv/amds/uganda_moh_treatment_guidelines.pdf.

Lawn S.D. , Myer L. , Bekker L.G. , Wood R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007; 21: 335–341.

Manosuthi W. , Van Tieu H. , Mankatitham W. Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2009; 23: 2467–2471.

Narita M. , Ashkin D. , Hollender E.S. , Pitchenick A.E. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158: 157–161.

Navas E. , Martin-Davila P. , Moreno L. Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Intern Med 2002; 162: 97–99.

Elliott J.H. , Vohith K. , Saramony S. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J Infect Dis 2009; 200: 1736–1745.

Lawn S.D. , Bekker L.G. , Miller R.F. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005; 5: 361–373.

Abdool Karim S.S. , Naidoo K. , Grobler A. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010; 362: 697–706.

Abdool Karim S. , Naidoo K. , Padayatchi N. Optimal timing of ART during TB therapy: findings of the SAPiT Trial. 18th Conference on Retroviruses and Opportunistic Infections. 27 February–2-March 2011, Boston, MA, USA. Abstract 39LB.

Eshun-Wilson I. , Havers F. , Nachega J.B. Evaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings. J Int Assoc Physicians AIDS Care (Chic) 2010; 9: 104–108.

Havlir D. , Ive P. , Kendall M. International randomized trial of immediate vs early ART in HIV+ patients treated for TB: ACTG 5221 STRIDE Study. 18th Conference on Retroviruses and Opportunistic Infections. 27 February–2-March 2011, Boston, MA, USA. Abstract 38.

Manosuthi W. , Kiertiburanakul S. , Phoorisri T. , Sungkanuparph S. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. J Infect 2006; 53: 357–363.

Republic of Uganda Ministry of Health. Manual of the National Tuberculosis and Leprosy Programme. (Updated 2010. Accessed 13 June 2011.) Available from http://www.who.int/hiv/pub/guidelines/uganda_tb.pdf.

Breton G. , Duval X. , Estellat C. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004; 39: 1709–1712.

Meintjes G. , Wilkinson R.J. , Morroni C. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2010; 24: 2381–2390.

Pepper D.J. , Marais S. , Maartens G. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009; 48: e96–e107.

Müller M. , Wandel S. , Colebunders R. , Attia S. , Furrer H. , Egger M. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10: 251–261.

Huyst V. , Lynen L. , Bottieau E. , Zolfo M. , Kestens L. , Colebunders R. Immune reconstitution inflammatory syndrome in an HIV/TB co-infected patient four years after starting antiretroviral therapy. Acta Clin Belg 2007; 62: 126–129.

Haddow L.J. , Colebunders R. , Meintjes G. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis 2010; 10: 791–802.